OraSure Technologies | OSUR - Current Assets


OraSure Technologies reported $240.78M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Agilent USD 4.62B 21M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Bio Techne USD 688.05M 50.62M Mar/2026
Bio-Rad Laboratories USD 2.94B 35.9M Mar/2026
Bruker USD 2.1B 108.9M Mar/2026
Cerus USD 174.38M 7.26M Dec/2025
Charles River Laboratories USD 1.49B 41.76M Mar/2026
Danaher USD 13.94B 1.18B Mar/2026
Dentsply International USD 1.85B 178M Mar/2026
Dexcom USD 4.33B 298.4M Mar/2026
Illumina USD 2.74B 551M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
Intuitive Surgical USD 11.52B 881.5M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Mettler Toledo International USD 1.33B 30.76M Mar/2026
Myriad Genetics USD 312.8M 19.8M Mar/2026
OraSure Technologies USD 240.78M 21.13M Mar/2026
Quidel USD 1.38B 70.3M Mar/2026
Repligen USD 1.16B 23.98M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
STAAR Surgical USD 312.4M 853K Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Trinity Biotech USD 35.52M 2.52M Sep/2025
Waters USD 3.72B 1.73B Mar/2026